Baseline patient characteristics (n = 198). Data are n (%) or median (interquartile range).
| Characteristics | Values |
|---|---|
| Female | 142 (71.7) |
| Age, yrs | 56.2 (44.6–66.5) |
| Body mass index, kg/m2 | 27.2 (24.0–30.8) |
| Current and former smoker | 107 (54.0) |
| Weeks of polyarthritis at baseline | 16 (12–27) |
| RF positive | 124 (62.6) |
| Anti-CCP positive | 109 (56.2) |
| Shared epitope positive | 119 (61.0) |
| DAS28 | 5.5 (4.7–6.4) |
| PGA, VAS, 0–100 mm | 54.0 (34.0–70.0) |
| Erosive disease | 36 (23.5) |
| Modified total Sharp score | 2.0 (0.0–7.0) |
| Physical function, mHAQ, 0–3 | 0.63 (0.25–1.13) |
| Pain, VAS, 0–100 mm | 57.0 (30.5–75.0) |
| Fatigue, VAS, 0–100 mm | 50.5 (23.0–69.0) |
| PtGA, VAS, 0–100 mm | 49.0 (26.0–64.8) |
| Helplessness, RAI, 5–25 | 14.0 (10.0–18.3) |
VAS: visual analog scale; mHAQ: modified Health Assessment Questionnaire; RAI: Rheumatology Attitudes Index; RF: rheumatoid factor; anti-CCP: anticyclic citrullinated peptide antibodies; DAS28: Disease Activity Score in 28 joints; PGA: physician’s global assessment; PtGA: patient’s global assessment.